We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVVE:NASDAQNuvve Holding Corp. Analysis

Data as of 2026-05-23 - not real-time

$0.38

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The stock trades at $0.381, far below its 20‑day SMA (0.354) and 50‑day SMA (0.544), indicating bearish price action. RSI 41 suggests weak momentum, while MACD shows a slight bullish histogram but both line and signal remain negative. Volume is decreasing and 30‑day volatility exceeds 139%, highlighting a thinly traded, highly erratic market. Fundamental picture is equally grim: revenue of $4.79 M grew 9 % YoY but gross margin is –34 %, operating margin –3.4 %, and the company burned $16.6 M in operating cash. Debt of $7.07 M dwarfs the $5.47 M cash balance, yielding a debt‑to‑equity of 279 and a negative book value per share.
Despite the distress, the price‑to‑sales multiple of 0.42 is well below industry norms, implying a potential undervaluation if the V2G platform can capture market share. The sector (consumer cyclical / specialty retail) and emerging V2G technology carry medium to high regulatory and sector risk, while the company’s geographic footprint in the US, Europe and Japan adds moderate geographic exposure. The Fear & Greed Index shows “Extreme Greed”, but the stock’s beta of 0.54 suggests limited correlation with market moves. Overall, the combination of severe financial weakness, high volatility, and uncertain adoption makes the stock a high‑risk play.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • price below short‑ and medium‑term SMAs indicating bearish momentum
  • decreasing volume and extreme 30‑day volatility
  • negative earnings, cash flow and high debt burden

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside from emerging V2G market adoption
  • price near support level with room for modest rebound
  • ongoing financial distress limiting near‑term upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • secular demand for vehicle‑to‑grid solutions could improve fundamentals
  • low market‑cap offers upside if technology succeeds
  • significant regulatory and execution risk remains high

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
P/E Ratio-0.0
ROE-5084.87%
ROA-117.65%
Debt/Equity279.37
P/B Ratio-0.4
Op. Cash Flow$-16627127
Free Cash Flow$-14641626

Technical Analysis

TrendBearish
RSI41.5
Support$0.23
Resistance$0.45
MA 20$0.35
MA 50$0.54
MA 200$5.88
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.54
Volatility139.08%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.